All In MedTech

FDA Clearance Tracker · P080030-S004

GLAUKOS TRABECULAR MICRO BYPASS STENT MODEL GTS100R/L

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 8, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080030-S004
Device name
GLAUKOS TRABECULAR MICRO BYPASS STENT MODEL GTS100R/L
Applicant location
Laguna Hills, CA
Received
Jul 20, 2012
Decided
Mar 8, 2013
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P080030

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OGO

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Glaukos Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.